| (210) | Number of the EPO application | 17817547 |
| (220) | Filing date of the EPO application | 2017.11.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 47/2020, 2020.11.18 |
| (110) | EPO patent number | 3548493 |
| (21) | Number of the application | e 2019 1130 |
| (71) | Name(s) of applicant(s), code of the country | MERCK SHARP & DOHME LLC, US; |
| (72) | Name(s) of inventor(s), code of the country | GRAHAM Thomas H., US;
YU Tao, US;
ZHANG Yonglian, US;
MCCAULEY John A., US; |
| (73) | Name(s) of owner(s), code of the country | MERCK SHARP & DOHME CORP., US; |
| (54) | Title of the invention | TETRACYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 487/16 (2006.01.01); C07D 498/16 (2006.01.01); A61P 31/18 (2006.01.01); A61K 31/4985 (2006.01.01); A61K 31/5365 (2006.01.01); A61K 31/424 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.11.30 |
| (30) | Priority | 201662429470 P, 2016.12.02, US |
| (86) | International application | PCT/US2017/063831, 2017.11.30 |
| (87) | International publication | WO 2018/102485, 2018.06.07 |